Global Biosimilar Monoclonal Antibodies Sales Market Report 2018 - Market Analysis

QYRlogo

This report studies the global Biosimilar Monoclonal Antibodies market status and forecast, categorizes the global Biosimilar Monoclonal Antibodies market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

A monoclonal antibody is a type of protein made in the laboratory that can bind to substances in the body, including cancer cells. A monoclonal antibody is made so that it binds to only one substance to treat different types of cancer. There are several types of monoclonal antibodies that are being used to treat certain types of cancer. Laboratory production of monoclonal antibodies is produced from clones of only one cell which means that every monoclonal antibody produced by the cell is the same due to which they are called as biosimilar monoclonal antibodies. Each monoclonal antibody recognizes one particular protein. They work in different ways depending on the protein they are targeting, hence different monoclonal antibodies are required to be made to target different types of cancer.

The major players covered in this report
    Pfizer, Inc.
    Novartis AG
    Reliance Life Sciences
    Allergan plc
    Coherus BioSciences, Inc.
    Biocon
    Dr. Reddy's Laboratories Ltd.
    Boehringer Ingelheim GmbH
    BioXpress Therapeutics SA
    Intas Pharmaceuticals Limited
    BIOCAD
    Genor BioPharma Co. Ltd
    Celltrion, Inc.

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
    United States
    Europe
    China
    Japan
    Southeast Asia
    India

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Rituximab
    Infliximab
    Abciximab
    Trastuzumab
    Adalimumab
    Bevacizumab

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Oncology
    Chronic and Autoimmune Diseases
    Growth Hormone Deficiency
    Infectious Diseases
    Others

The study objectives of this report are:
    To analyze and study the global Biosimilar Monoclonal Antibodies sales, value, status (2013-2017) and forecast (2018-2025);
    To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
    Focuses on the key Biosimilar Monoclonal Antibodies players, to study the sales, value, market share and development plans in future.
    Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
    To define, describe and forecast the market by type, application and region.
    To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
    To identify significant trends and factors driving or inhibiting the market growth.
    To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
    To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
    To strategically profile the key players and comprehensively analyze their growth strategies.

Request Sample Report and TOC http://www.qyresearchglobal.com/goods-1766359.html

About Us:

QY Research established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), expert’s resources (included energy automotive chemical medical ICT consumer goods etc.

QY Research Achievements:  

Year of Experience: 11 Years

Consulting Projects: 500+ successfully conducted so far

Global Reports: 5000 Reports Every Years

Resellers Partners for Our Reports: 150 + Across Globe

Global Clients: 34000+

Contact US

QY Research, INC.

Tina

17890 Castleton, Suite 218,

City of industry, CA – 91748

USA: +1 626 295 2442

Email: sales@qyrsearchglobal.com 

Web: www.qyresearchglobal.com

For other region, contact number given below

+86 108 294 5717 Beijing

+852 3062 8839 HK